ESC 365 - Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

HFA Premium Access

Long-term outcome in the pivotal MOMENTUM 3 trial: medical resource use and cost implications

Session: Late breaking trial III - Innovative and device therapy

Topic: Ventricular Assist Devices

Speaker: Professor M. Mehra (Boston, US)

Event: Heart Failure 2018

Congress Presentation

Add to my library

About the speaker

Professor Mandeep Mehra

Mass General Brigham, Boston (United States of America)

44 presentations

13 followers

11 more presentations in this session

Upgrades from a previous device compared to de novo CRT implantation in the CRT Survey II: a European Society of Cardiology survey of cardiac resynchronization therapy in 11.088 patients

Speaker: Professor C. Linde (Stockholm, SE)

Discussion - CRT Survey II

Discussion - MOMENTUM 3

Cardiac contractility modulation improves peak VO2, long-term survival and hospitalisations in heart failure with reduced ejection fraction; evidence from FIX-5C and the EU registry

Speaker: Professor G. Hasenfuss (Goettingen, DE)

Discussion - FIX-5C and the EU registry

Access the full session

Late breaking trial III - Innovative and device therapy

Speakers: Professor M. Mehra, Professor C. Linde, Professor G. Hasenfuss

About the event

Heart Failure 2018

26 May - 29 May 2018

Sessions Presentations

Congress

ESC 365 is supported by

bristol-myers-squibb

Explore sponsored resources

novartis

Explore sponsored resources